Prof. Dr. Michael Sticherling



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany (2020) Heratizadeh A, Haufe E, Stoelzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, et al. Journal article Itching and Neurodermatitis: Results from the German Neurodermatitis Register TREATgermany (2020) Haufe E, Heinrich L, Weisshaar E, Abraham S, Heratizadeh A, Harder I, Kleinheinz A, et al. Conference contribution Insights From the Apremilast After Switching From Fumaric Acid Ester Treatment (APART) Study: An Interim Real-World Safety Analysis (2020) Mrowietz U, Ertner K, Sticherling M, Grosse V, Popp G, Schwichtenberg U, Karl L, et al. Conference contribution Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS) (2020) Thaci D, Pinter A, Sebastian M, Termeer C, Sticherling M, Gerdes S, Wegner S, et al. Journal article Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study (2020) Reich K, Koerber A, Mrowietz U, Sticherling M, Sieder C, Frueh J, Bachhuber T Journal article Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: Results from a claims database analysis (2020) Rech J, Sticherling M, Stoessel D, Biermann MH, Häberle BM, Reinhardt M Journal article COVID-19 and implications for dermatological and allergological diseases (2020) Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, et al. Journal article, Review article Travel-associated infectious skin diseases (2020) Rongisch R, Schmidt E, Deresz N, Deresz K, Schoefer H, Schaekel K, Jakob T, et al. Journal article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article Successful treatment of ulcerative necrobiosis lipoidica with JAK inhibitor (2020) Erfurt-Berge C, Sticherling M Journal article